Significados de familial hypercholesterolemia en inglés

It is the only life prolonging therapy for patients with homozygous familial hypercholesterolemia.

This mutation was found in a patient with the clinical syndrome of homozygous familial hypercholesterolemia.

Children with homozygous familial hypercholesterolemia are at risk for early cardiovascular events secondary to coronary artery disease.

It was shown that PCSK9 levels positively correlate with carotid artery intima-media thickness in patients with familial hypercholesterolemia.

We report a 5.5-yr-old child initially misdiagnosed with heterozygous familial hypercholesterolemia and treated by low-fat diet only.

Mutations in LDLR lead to familial hypercholesterolemia, a common disease affecting 1 in 500 of the human population.

The disorder, called familial hypercholesterolemia, is a genetic disease that results in elevated bad cholesterol levels and increased risk of premature heart disease.

The patients in the Phase 3 study had homozygous familial hypercholesterolemia, a rare condition that hinders their ability to properly metabolize the fatty substance.

Lojuxta is used to treat a rare life-threatening disease called Homozygous Familial Hypercholesterolemia.

Familial hypercholesterolemia is an autosomal codominant disorder associated with markedly elevated plasma concentration of LDL-cholesterol and increased cardiovascular risk.

Endocrinologist and Professor of Science Communication at the University of Otago, Jean Fleming on human anatomy; rare genetic diseases - Familial hypercholesterolemia.

Familial hypercholesterolemia is seen in about one of every 200 to 500 adults in Europe and North America, the panel writes.